150 related articles for article (PubMed ID: 17603930)
1. Characterization of redox state of two human prostate carcinoma cell lines with different degrees of aggressiveness.
Chaiswing L; Bourdeau-Heller JM; Zhong W; Oberley TD
Free Radic Biol Med; 2007 Jul; 43(2):202-15. PubMed ID: 17603930
[TBL] [Abstract][Full Text] [Related]
2. Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.
Minelli A; Bellezza I; Tucci A; Rambotti MG; Conte C; Culig Z
Prostate; 2009 Apr; 69(5):538-47. PubMed ID: 19107848
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.
Kumar B; Koul S; Khandrika L; Meacham RB; Koul HK
Cancer Res; 2008 Mar; 68(6):1777-85. PubMed ID: 18339858
[TBL] [Abstract][Full Text] [Related]
4. Distinct response to ionizing radiation of human prostate cell lines.
Cardile V; Bellia M; Lombardo L; Scifo C; Renis M
Oncol Rep; 2005 Oct; 14(4):981-5. PubMed ID: 16142361
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate.
Janssen T; Darro F; Petein M; Raviv G; Pasteels JL; Kiss R; Schulman CC
Cancer; 1996 Jan; 77(1):144-9. PubMed ID: 8630922
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG
Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of defense enzymes is responsible for low reactive oxygen species in malignant prostate cancer cells.
Lim HW; Hong S; Jin W; Lim S; Kim SJ; Kang HJ; Park EH; Ahn K; Lim CJ
Exp Mol Med; 2005 Oct; 37(5):497-506. PubMed ID: 16264276
[TBL] [Abstract][Full Text] [Related]
8. [Knockdown of STAT3 expression using siRNA inhibits the growth of prostate cancer cell lines].
Gao LF; Xu DQ; Shao YT; Zhao D; Zhao XJ
Zhonghua Nan Ke Xue; 2005 Jan; 11(1):29-33, 37. PubMed ID: 15704678
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human uteroglobin inhibits the in vitro invasiveness of human metastatic prostate tumor cells and the release of arachidonic acid stimulated by fibroblast-conditioned medium.
Leyton J; Manyak MJ; Mukherjee AB; Miele L; Mantile G; Patierno SR
Cancer Res; 1994 Jul; 54(14):3696-9. PubMed ID: 8033085
[TBL] [Abstract][Full Text] [Related]
10. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells.
Skvortsova I; Skvortsov S; Stasyk T; Raju U; Popper BA; Schiestl B; von Guggenberg E; Neher A; Bonn GK; Huber LA; Lukas P
Proteomics; 2008 Nov; 8(21):4521-33. PubMed ID: 18821526
[TBL] [Abstract][Full Text] [Related]
11. Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines.
Chow L; Rezmann L; Imamura K; Wang L; Catt K; Tikellis C; Louis WJ; Frauman AG; Louis SN
Prostate; 2008 May; 68(6):651-60. PubMed ID: 18288685
[TBL] [Abstract][Full Text] [Related]
12. Effects of irradiation on the [Methyl-3H]choline uptake in the human prostate cancer cell lines LNCaP and PC3.
Holzapfel K; Müller SA; Seidl C; Grosu AL; Schwaiger M; Senekowitsch-Schmidtke R
Strahlenther Onkol; 2008 Jun; 184(6):319-24. PubMed ID: 18535808
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effects of treosulfan on prostate cancer cell lines.
Feyerabend S; Feil G; Krug J; Kassen A; Stenzl A
Anticancer Res; 2007; 27(4B):2403-8. PubMed ID: 17695531
[TBL] [Abstract][Full Text] [Related]
14. Effects of triptorelin, a gonadotropin-releasing hormone agonist, on the human prostatic cell lines PC3 and LNCaP.
Ravenna L; Salvatori L; Morrone S; Lubrano C; Cardillo MR; Sciarra F; Frati L; Di Silverio F; Petrangeli E
J Androl; 2000; 21(4):549-57. PubMed ID: 10901441
[TBL] [Abstract][Full Text] [Related]
15. [Over-expression of HIF-1alpha induces EMT of human prostate cancer cells].
Luo Y; He DL; Jiang YG; Li MC; Ning L; Shen SL
Zhonghua Nan Ke Xue; 2008 Sep; 14(9):800-4. PubMed ID: 18998463
[TBL] [Abstract][Full Text] [Related]
16. [Type IV collagenase expression in human prostate carcinoma cell lines with different metastasis potentials].
Zhang LL; He DL; Li X; Li L; Zhu GD; Wang XY
Zhonghua Nan Ke Xue; 2006 Oct; 12(10):913-6. PubMed ID: 17121023
[TBL] [Abstract][Full Text] [Related]
17. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
[TBL] [Abstract][Full Text] [Related]
18. JunD mediates androgen-induced oxidative stress in androgen dependent LNCaP human prostate cancer cells.
Mehraein-Ghomi F; Lee E; Church DR; Thompson TA; Basu HS; Wilding G
Prostate; 2008 Jun; 68(9):924-34. PubMed ID: 18386285
[TBL] [Abstract][Full Text] [Related]
19. Leptin and adiponectin interact in the regulation of prostate cancer cell growth via modulation of p53 and bcl-2 expression.
Mistry T; Digby JE; Desai KM; Randeva HS
BJU Int; 2008 May; 101(10):1317-22. PubMed ID: 18279445
[TBL] [Abstract][Full Text] [Related]
20. Zinc deficiency reduces paclitaxel efficacy in LNCaP prostate cancer cells.
Killilea AN; Downing KH; Killilea DW
Cancer Lett; 2007 Dec; 258(1):70-9. PubMed ID: 17905512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
